Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
President Macron has announced a ban on mobile phones in French high schools.
Read More
French gendarmes have issued a new appeal for information as the investigation into the killing of Karen Carter enters its seventh month with no major...
Read More
President Macron has confirmed that voluntary national service will be introduced in France
Read More
The French government has suspended a planned rise in property tax until next spring, Prime Minister Sébastien Lecornu told the Senate on Wednesday. T...
Read More
A homeless man accused of firing a shot which seriously injured another homeless person in Nice has appeared in court. The man in his fifties claimed ...
Read More
